{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:58:51Z","timestamp":1793761131799,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,3,19]],"date-time":"2011-03-19T00:00:00Z","timestamp":1300492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11892-011-0189-8","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T20:47:35Z","timestamp":1300394855000},"page":"179-184","source":"Crossref","is-referenced-by-count":97,"title":["Adipose Tissue Dysfunction in Polycystic Ovary Syndrome"],"prefix":"10.1007","volume":"11","author":[{"given":"Jennifer","family":"Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Pratley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,19]]},"reference":[{"key":"189_CR1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"\u2022 March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ: The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010, 25:544\u2013551. This study compares the prevalence of PCOS using various diagnostic criteria and indicates that PCOS may be much more prevalent than commonly appreciated.","journal-title":"Hum Reprod"},{"issue":"1","key":"189_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","journal-title":"Hum Reprod"},{"issue":"7","key":"189_CR3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.molmed.2006.05.006","volume":"12","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Papavassiliou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med. 2006;12(7):324\u201332.","journal-title":"Trends Mol Med"},{"issue":"7","key":"189_CR4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","volume":"18","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab. 2007;18(7):280\u20135.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"189_CR5","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","volume":"95","author":"HF Escobar-Morreale","year":"2011","unstructured":"Escobar-Morreale HF, Luque-Ram\u00edrez M, Gonz\u00e1lez F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011;95(3):1048\u201358.","journal-title":"Fertil Steril"},{"issue":"4","key":"189_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","volume":"16","author":"LJ Moran","year":"2010","unstructured":"\u2022 Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010, 16(4):347\u201363. This study highlights the markedly increased risk for diabetes among women with PCOS.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"189_CR7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1464-5491.2010.02994.x","volume":"27","author":"J Tomlinson","year":"2010","unstructured":"Tomlinson J, Millward A, Stenhouse E, Pinkney J. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced? Diabet Med. 2010;27(5):498\u2013515.","journal-title":"Diabet Med"},{"issue":"19","key":"189_CR8","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","volume":"166","author":"F Alvarez-Blasco","year":"2006","unstructured":"Alvarez-Blasco F, Botella-Carretero JI, San Mill\u00e1n JL, Escobar-Morreale HF. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med. 2006;166(19):2081\u20136.","journal-title":"Arch Intern Med"},{"issue":"6","key":"189_CR9","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"189_CR10","doi-asserted-by":"crossref","unstructured":"Escobar-Morreale H, San Milla J, Abdominal adiposity and the polycystic ovary syndrome TRENDS in Endocrinology and Metabolism Vol.18 No.7","DOI":"10.1016\/j.tem.2007.07.003"},{"key":"189_CR11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2337\/diabetes.46.3.456","volume":"46","author":"JB Albu","year":"1997","unstructured":"Albu JB, Kovera AJ, Frager DH, Johnson JA, Pi-Sunyer FX. Visceral fat and race-dependent health risks in obese non-diabetic premenopausal women. Diabetes. 1997;46:456\u201362.","journal-title":"Diabetes"},{"key":"189_CR12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2265.2001.01303.x","volume":"55","author":"P Marsden","year":"2001","unstructured":"Marsden P, Murdoch A, Taylor R. Tissue insulin sensitivity and body weight in polycystic ovary syndrome. Clin Endocrinol. 2001;55:191\u20139.","journal-title":"Clin Endocrinol"},{"key":"189_CR13","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1210\/jc.2010-1290","volume":"96","author":"L Manner\u00e5s-Holm","year":"2011","unstructured":"\u2022\u2022 Manner\u00e5s-Holm L, Leonhardt H, Kullberg J, Jennische A, et al. Adipose Tissue Has Aberrant Morphology and Function in PCOS: Enlarged Adipocytes and Low Serum Adiponectin, But Not Circulating Sex Steroids, Are Strongly Associated with Insulin Resistance. J. Clin. Endocrinol. Metab. 2011, 96:E304-E311. This study comprehensively examines adipose tissue morphology and function in women with PCOS.","journal-title":"J Clin Endocrinol Metab"},{"key":"189_CR14","doi-asserted-by":"crossref","first-page":"E2500","DOI":"10.1210\/jc.2006-2725","volume":"92","author":"E Carmina","year":"2007","unstructured":"Carmina E, Bucchieri S, Esposito A, Del Puente A, et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab. 2007;92:E2500\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"189_CR15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11892-005-0071-7","volume":"5","author":"YH Lee","year":"2005","unstructured":"Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep. 2005;5(1):70\u20135.","journal-title":"Curr Diab Rep"},{"issue":"4","key":"189_CR16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1467-789X.2001.00042.x","volume":"2","author":"DB Hausman","year":"2001","unstructured":"Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ. The biology of white adipocyte proliferation. Obes Rev. 2001;2(4):239\u201354.","journal-title":"Obes Rev"},{"key":"189_CR17","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796\u2013808.","journal-title":"J Clin Invest"},{"key":"189_CR18","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","volume":"89","author":"EE Kershaw","year":"2004","unstructured":"Kershaw EE. Flier JS Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548\u201356.","journal-title":"J Clin Endocrinol Metab"},{"key":"189_CR19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1172\/JCI107258","volume":"52","author":"LB Salans","year":"1973","unstructured":"Salans LB, Cushman SW, Weismann RE. Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients. J Clin Invest. 1973;52:929\u201341.","journal-title":"J Clin Invest"},{"key":"189_CR20","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s001250051560","volume":"43","author":"C Weyer","year":"2000","unstructured":"Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance. Diabetologia. 2000;43:1498\u2013506.","journal-title":"Diabetologia"},{"key":"189_CR21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01225573","volume":"8","author":"W Leonhardt","year":"1972","unstructured":"Leonhardt W, Hanefeld M, Schneider H, Haller H. Human adipocyte volumes: maximum size, and correlation to weight index in maturity onset-diabetes. Diabetologia. 1972;8:287\u201391.","journal-title":"Diabetologia"},{"issue":"5","key":"189_CR22","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1210\/jc.2002-021573","volume":"88","author":"G Faulds","year":"2003","unstructured":"Faulds G, Ryd\u00e9n M, Ek I, Wahrenberg H, Arner P. Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome. J Clin Endocrinol Metab. 2003;88(5):2269\u201373.","journal-title":"J Clin Endocrinol Metab"},{"key":"189_CR23","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1210\/jc.82.4.1147","volume":"82","author":"I Ek","year":"1997","unstructured":"Ek I, Arner P, Bergqvist A, Carlstrom K, Wahrenberg H. Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance? J Clin Endocrinol Metab. 1997;82:1147\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"189_CR24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2337\/diabetes.51.2.484","volume":"51","author":"I Ek","year":"2002","unstructured":"Ek I, Arner P, Ryde M, Holm C, Thorne A, Hoffstedt J, et al. A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes. 2002;51:484\u201392.","journal-title":"Diabetes"},{"issue":"8","key":"189_CR25","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/humrep\/dep122","volume":"24","author":"KM Seow","year":"2009","unstructured":"Seow KM, Tsai YL, Hwang JL, Hsu WY, Ho LT, Juan CC. Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome. Hum Reprod. 2009;24(8):1982\u20138.","journal-title":"Hum Reprod"},{"key":"189_CR26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00125-003-1324-0","volume":"47","author":"A Dicker","year":"2004","unstructured":"Dicker A, Ryden M, Nashund E, Muehlen IE, Wiren M, Lafontan M, et al. Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots. Diabetologia. 2004;47:420\u20138.","journal-title":"Diabetologia"},{"key":"189_CR27","first-page":"E197","volume":"264","author":"D Rosenbaum","year":"1993","unstructured":"Rosenbaum D, Haber RS, Dunaif A. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am J Physiol. 1993;264:E197\u2013202.","journal-title":"Am J Physiol"},{"issue":"6","key":"189_CR28","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.fertnstert.2007.10.025","volume":"90","author":"W Chang","year":"2008","unstructured":"Chang W, Goodarzi M, Williams H, Magoffin D, Pall M, Azziz R. Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3. Fertil Steril. 2008;90(6):2291\u20137.","journal-title":"Fertil Steril"},{"key":"189_CR29","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.metabol.2006.12.021","volume":"56","author":"A Corbould","year":"2007","unstructured":"Corbould A, Dunaif A. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome. Metab Clin Exp. 2007;56:716\u201322.","journal-title":"Metab Clin Exp"},{"key":"189_CR30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1677\/joe.1.07070","volume":"192","author":"A Corbould","year":"2007","unstructured":"Corbould A. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J Endocrinol. 2007;192:585\u201394.","journal-title":"J Endocrinol"},{"issue":"1","key":"189_CR31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/79111","volume":"26","author":"E Danforth Jr","year":"2000","unstructured":"Danforth Jr E. Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet. 2000;26(1):13.","journal-title":"Nat Genet"},{"issue":"6","key":"189_CR32","doi-asserted-by":"crossref","first-page":"E958","DOI":"10.1152\/ajpendo.00544.2003","volume":"286","author":"PA Permana","year":"2004","unstructured":"Permana PA, Nair S, Lee YH, Luczy-Bachman G, Vozarova De Courten B, Tataranni PA. Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity. Am J Physiol Endocrinol Metab. 2004;286(6):E958\u201362.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"189_CR33","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bbrc.2004.03.152","volume":"317","author":"X Yang","year":"2004","unstructured":"Yang X, Jansson PA, Nagaev I, Jack MM, Carvalho E, Sunnerhagen KS, et al. Evidence of impaired adipogenesis in insulin resistance. Biochem Biophys Res Commun. 2004;317(4):1045\u201351.","journal-title":"Biochem Biophys Res Commun"},{"key":"189_CR34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/jc.2006-1665","volume":"92","author":"M Corton","year":"2007","unstructured":"Corton M, Botella-Carretero J, Bengur\u0131a A, Villuendas G, Zaballos A, et al. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92:328\u201337.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"189_CR35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mce.2008.08.019","volume":"296","author":"V Gupta","year":"2008","unstructured":"Gupta V, Bhasin S, Guo W, Singh R, Miki R, Chauhan P, et al. Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes. Mol Cell Endocrinol. 2008;296(1\u20132):32\u201340.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"189_CR36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1677\/JOE-10-0217","volume":"207","author":"AV Roland","year":"2010","unstructured":"Roland AV, Nunemaker CS, Keller SR, Moenter SM. Prenatal androgen exposure programs metabolic dysfunction in female mice. J Endocrinol. 2010;207(2):213\u201323.","journal-title":"J Endocrinol"},{"issue":"9","key":"189_CR37","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s00125-005-1867-3","volume":"48","author":"YH Lee","year":"2005","unstructured":"Lee YH, Nair S, Rousseau E, Allison DB, Page GP, Tataranni PA, et al. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia. 2005;48(9):1776\u201383.","journal-title":"Diabetologia"},{"key":"189_CR38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","volume":"372","author":"Y Zhang","year":"1994","unstructured":"Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425\u201332.","journal-title":"Nature"},{"key":"189_CR39","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1195-1155","volume":"1","author":"M Maffei","year":"1995","unstructured":"Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and obRNA in obese and weight-reduced subjects. Nat Med. 1995;1:1155\u201361.","journal-title":"Nat Med"},{"issue":"6","key":"189_CR40","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.82.6.1687","volume":"82","author":"CS Mantzoros","year":"1997","unstructured":"Mantzoros CS, Dunaif A, Flier JS. Leptin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82(6):1687\u201391.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"189_CR41","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.fertnstert.2008.03.007","volume":"91","author":"E Carmina","year":"2009","unstructured":"\u2022 Carmina E, Bucchieri S, Mansueto P, Rini G, Ferin M, Lobo R. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertility and Sterility 2009, 91(4) supplement: 1332\u20131335. In this study, differences in several adipokines were demonstrated in ovulatory and anovulatory women with PCOS.","journal-title":"Fertil Steril"},{"key":"189_CR42","doi-asserted-by":"crossref","first-page":"E1930","DOI":"10.1210\/jc.86.5.1930","volume":"86","author":"C Weyer","year":"2001","unstructured":"Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:E1930\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"189_CR43","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1210\/jc.2009-1557","volume":"95","author":"A O\u2019Connor","year":"2010","unstructured":"O\u2019Connor A, Phelan N, Kyaw T, Boran G, Gibney J, Roche HM. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance. J Clin Endocrinol Metab. 2010;95:1378\u201385.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"189_CR44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/humupd\/dmp006","volume":"15","author":"KA Toulis","year":"2009","unstructured":"\u2022 Toulis KA, Goulis DG, Farmakiotis D, Georgopolous NA, Katsikis I, Tarlatzis BC, Papadimas I, Panidis D. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Human Reproduction Update 2009; 15 (3): 297\u2013307. This systematic review documents the low levels of adiponectin observed in women with PCOS.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"189_CR45","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/09513590802653833","volume":"25","author":"Y Murat","year":"2009","unstructured":"Murat Y, Bukan N, Demirci H, Ozturk C, Kan E, Ayvaz G, et al. Serum resistin and adiponectin levels in women with polycystic ovary syndrome. Gynecol Endocrinol. 2009;25(4):246\u201352.","journal-title":"Gynecol Endocrinol"},{"key":"189_CR46","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1530\/EJE-08-0387","volume":"159","author":"B Mlinar","year":"2008","unstructured":"Mlinar B, Pfeifer M, Vrtachnik-Bokal E, Jensterle M, Marc J. Decreased lipin 1\u03b2 expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome. Eur J Endocrinol. 2008;159:833\u20139.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"189_CR47","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm.1964","volume":"15","author":"S Nishimura","year":"2009","unstructured":"Nishimura S, Manabe I, Nagasaki M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15(8):914\u201320.","journal-title":"Nat Med"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-011-0189-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-011-0189-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-011-0189-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T05:36:36Z","timestamp":1560058596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-011-0189-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,19]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["189"],"URL":"https:\/\/doi.org\/10.1007\/s11892-011-0189-8","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,19]]}}}